Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic high affinity T cell receptor targeting a KRASG12D cancer neoantigen
Andrew J. Poole, V. Karuppiah, Annabelle Hartt, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

T-cell-engaging bispecific antibodies in cancer
Niels W.C.J. van de Donk, Sonja Zweegman
The Lancet (2023) Vol. 402, Iss. 10396, pp. 142-158
Closed Access | Times Cited: 123
Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial
Shubham Pant, Zev A. Wainberg, Colin D. Weekes, et al.
Nature Medicine (2024) Vol. 30, Iss. 2, pp. 531-542
Open Access | Times Cited: 81
T cell receptor therapeutics: immunological targeting of the intracellular cancer proteome
Christopher A. Klebanoff, Smita S. Chandran, Brian M. Baker, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 12, pp. 996-1017
Open Access | Times Cited: 66
The landscape of T cell antigens for cancer immunotherapy
Aviyah Peri, Nadja Salomon, Yochai Wolf, et al.
Nature Cancer (2023) Vol. 4, Iss. 7, pp. 937-954
Closed Access | Times Cited: 62
Exploiting the therapeutic implications of KRAS inhibition on tumor immunity
Míriam Molina‐Arcas, Julian Downward
Cancer Cell (2024) Vol. 42, Iss. 3, pp. 338-357
Open Access | Times Cited: 49
Mutant KRAS-activated circATXN7 fosters tumor immunoescape by sensitizing tumor-specific T cells to activation-induced cell death
Chi Zhou, Wenxin Li, Liang Zhenxing, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 30
KRAS G12V neoantigen specific T cell receptor for adoptive T cell therapy against tumors
Dan Lu, Yuan Chen, Min Jiang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 33
The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells
Jianping Li, Zhiwen Xiao, Donghui Wang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 29
Circular RNA‐based neoantigen vaccine for hepatocellular carcinoma immunotherapy
Fei Wang, Cai Guang, Yingchao Wang, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 15
TCR catch bonds nonlinearly control CD8 cooperation to shape T cell specificity
Rui Qin, Yong Zhang, Jiawei Shi, et al.
Cell Research (2025)
Open Access | Times Cited: 1
The potential applications of peptide-loading complex in cancer treatment
Zhidu Song, Ying Tao, Jiaxin You
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
T Cell Antigen Recognition and Discrimination by Electrochemiluminescence Imaging
Yajuan Yan, Ping Zhou, Lurong Ding, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 50
Closed Access | Times Cited: 17
Advancements and Challenges in Peptide-Based Cancer Vaccination: A Multidisciplinary Perspective
Dequan Liu, Lei Liu, Xinghan Li, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 950-950
Open Access | Times Cited: 8
Identification and affinity enhancement of T-cell receptor targeting a KRASG12V cancer neoantigen
Mengyu Zhang, Wei Xu, Lingjie Luo, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 6
Facts and Hopes on RAS Inhibitors and Cancer Immunotherapy
Jesse Boumelha, Míriam Molina‐Arcas, Julian Downward
Clinical Cancer Research (2023) Vol. 29, Iss. 24, pp. 5012-5020
Open Access | Times Cited: 16
Immune vulnerabilities of mutant KRAS in pancreatic cancer
Noah Cheng, Robert H. Vonderheide
Trends in cancer (2023) Vol. 9, Iss. 11, pp. 928-936
Open Access | Times Cited: 11
Structural basis for T cell recognition of cancer neoantigens and implications for predicting neoepitope immunogenicity
Roy A. Mariuzza, Daichao Wu, Brian G. Pierce
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Facts and Hopes in Immunotherapy Strategies Targeting Antigens Derived from KRAS mutations
Gerald P. Linette, Adham S. Bear, Beatriz M. Carreno
Clinical Cancer Research (2024) Vol. 30, Iss. 10, pp. 2017-2024
Open Access | Times Cited: 4
A Thermosensitive Bi‐Adjuvant Hydrogel Triggers Epitope Spreading to Promote the Anti‐Tumor Efficacy of Frameshift Neoantigens
Yaohua Ke, Kai Xin, Yaping Tao, et al.
Advanced Science (2024) Vol. 11, Iss. 14
Open Access | Times Cited: 4
Novel insights into TCR-T cell therapy in solid neoplasms: optimizing adoptive immunotherapy
Weihuan Shao, Yiran Yao, Ludi Yang, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Ready, Set, Go: Setting Off on the Mission to Target KRAS in Colorectal Cancer
Andrew J. Pellatt, Deepak Bhamidipati, Vivek Subbiah
JCO Oncology Practice (2024) Vol. 20, Iss. 10, pp. 1289-1292
Closed Access | Times Cited: 4
TCR-mimicking STAR conveys superior sensitivity over CAR in targeting tumors with low-density neoantigens
Daosheng Huang, Yi Li, Wei Rui, et al.
Cell Reports (2024) Vol. 43, Iss. 11, pp. 114949-114949
Open Access | Times Cited: 4
The Evolving T Cell Receptor Recognition Code: The Rules Are More Like Guidelines
George I. Gray, P. Chukwunalu Chukwuma, Bassant Eldaly, et al.
Immunological Reviews (2025) Vol. 329, Iss. 1
Closed Access
SARS-CoV-2 B Epitope-Guided Neoantigen NanoVaccines Enhance Tumor-Specific CD4/CD8 T Cell Immunity through B Cell Antigen Presentation
Chengyi Li, Fang Ke, Shuai Mao, et al.
ACS Nano (2025)
Open Access
Reprogramming the Tolerogenic Immune Response Against Pancreatic Cancer Metastases by Lipid Nanoparticles Delivering a STING Agonist Plus Mutant KRAS mRNA
Xiao Xu, Xiang Wang, Yu‐Pei Liao, et al.
ACS Nano (2025)
Closed Access
Page 1 - Next Page

Scroll to top